4//SEC Filing
Davis Jefferson E 4
Accession 0001209191-21-008127
CIK 0001069308other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:50 PM ET
Size
5.8 KB
Accession
0001209191-21-008127
Insider Transaction Report
Form 4
Davis Jefferson E
Chief Business Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-02-03+100,000→ 100,000 totalExercise: $3.89Exp: 2031-02-03→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over four years as follows: 25% of the shares vest on February 3, 2022, and the remaining 75% of the shares vest quarterly over the remaining three years.
Documents
Issuer
Acer Therapeutics Inc.
CIK 0001069308
Entity typeother
Related Parties
1- filerCIK 0001844533
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:50 PM ET
- Size
- 5.8 KB